| 摘要 |
The invention provides a population of placental-derived adherent cells that are CD10+, CD34-, CD105+, and CD200+ for use in a method for treatment of an individual having a disease or injury of the heart or circulatory system. Said placental-derived adherent cells may additionally be one or more of CD45-, CD90+, or OCT-4+. |
| 申请人 |
Anthrogenesis Corporation |
发明人 |
ABBOT, Stewart;EDINGER, James;FRANCKI, Aleksander;HARIRI, Robert, J.;KAPLUNOVSKY, Aleksandr;LABAZZO, Kristen;LAW, Eric;PAREDES, Jennifer;WANG, Jia-lun;JANKOVIC, Vladimir;PADLIYA, Neerav |
